Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays

Journal of Medical Virology
Damien JeantetA Kay

Abstract

Occult hepatitis B virus (HBV) infections show little or no serological markers of viral infection, including the absence of hepatitis B surface antigen (HBsAg) which is the main marker of ongoing HBV infection. Such infections can be important in the context of blood and/or organ donations. To study whether mutations contribute to HBsAg seronegativity, S gene sequences from such patients were amplified and cloned. Sequencing revealed 12 clones from seven different patients which contained potentially important mutations. The sequences were subcloned into an expression vector and mutant HBsAgs were expressed in cell culture. The capacity of three HBsAg detection assays to recognise the mutant HBsAgs was studied. Three categories were found: mutant HBsAgs that are not recognised by the assays, those that are recognised as well as wild-type (WT) antigen and an intermediate category where detection of the mutant HBsAgs is reduced with respect to WT. Most of the isolates fall into the second category. Mutations can therefore contribute to HBsAg seronegativity in occult HBV infections, but in most cases the explanation is probably the low level of viral replication.

References

Jun 22, 1978·The New England Journal of Medicine·J H HoofnagleH J Zimmerman
Aug 11, 1990·Lancet·W F CarmanH C Thomas
Jul 1, 1991·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H E BlumJ R Wands
Mar 25, 1994·Journal of Molecular Biology·B Persson, P Argos
Dec 1, 1993·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T L FongJ H Hoofnagle
Jun 27, 1996·The New England Journal of Medicine·G B SchreiberJ J Korelitz
Aug 1, 1996·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P Bedossa, T Poynard
Sep 26, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·H Y HsuD S Chen
Dec 4, 1998·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·J PillonelA M Couroucé
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C PichoudF Zoulim
Mar 11, 1999·The New England Journal of Medicine·H B El-Serag, A C Mason
May 21, 1999·Journal of Medical Virology·K M WeinbergerW Jilg
Aug 14, 1999·Journal of Medical Virology·A J Zuckerman, J N Zuckerman
Mar 7, 2000·Clinical and Diagnostic Laboratory Immunology·H H KesslerR E Stauber
May 5, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J H IrelandW F Carman
Nov 14, 2000·Journal of Medical Virology·P GrobI Mushahwar
May 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Damien JeantetAlan Kay
Nov 26, 2003·Antiviral Research·Jane N Zuckerman, Arie J Zuckerman

❮ Previous
Next ❯

Citations

Sep 21, 2010·Medical Microbiology and Immunology·Stefan ReuterDieter Häussinger
Oct 13, 2009·Journal of Gastroenterology and Hepatology·Jorge S MottaFatima F Figueiredo
Jul 17, 2007·Clinical Microbiology Reviews·Alexandra Valsamakis
Nov 27, 2009·Journal of Clinical Microbiology·Quan YuanNing-Shao Xia
Dec 17, 2008·Virology Journal·Formijn J van HemertVladimir V Lukashov
Apr 8, 2011·World Journal of Gastroenterology : WJG·Rocio Aller de la FuenteGregorio Castellano
Apr 30, 2011·World Journal of Gastroenterology : WJG·Zeinab Nabil Ahmed Said
Mar 28, 2013·Hepatitis Research and Treatment·Mehdi Zobeiri
Mar 10, 2015·International Journal of Molecular Sciences·Xiaosong LiAilong Huang
Jan 21, 2016·Virology Journal·Zhenhua ZhangXu Li
Feb 3, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Annabelle Servant-DelmasSyria Laperche
Oct 27, 2009·Pathologie-biologie·S Marque-JuilletM Harzic
May 16, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Flavia G Piñeiro Y LeoneRodolfo H Campos
Mar 26, 2009·Journal of Medical Virology·Antigoni KatsoulidouAngelos Hatzakis
Jul 16, 2008·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Natalia M AraujoSelma A Gomes
Oct 24, 2013·Journal of Medical Virology·Mahmoud Reza PourkarimMarc Van Ranst
Jan 21, 2014·Journal of Viral Hepatitis·X Huang, F B Hollinger
Dec 17, 2009·Journal of Viral Hepatitis·F B Hollinger, G Sood
Aug 29, 2014·Journal of Medical Virology·Eleanor A PowellJason T Blackard
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Bernard Weber
Nov 23, 2006·Journal of Hepatology·Giovanni RaimondoGiovanni Squadrito
Mar 29, 2006·Journal of Virological Methods·Bernard WeberJaques Ritter
Feb 19, 2011·Hepatitis Research and Treatment·Francisco C A MelloNatalia M Araujo
Feb 19, 2015·Human Vaccines & Immunotherapeutics·Qing YeWei Li
Jul 14, 2012·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Seyed Moayed AlavianSeyed Mohammad Jazayeri
Feb 8, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·I Chemin, C Trépo
Oct 16, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Gerald Y MinukCarla Osiowy
Apr 20, 2006·Journal of Medical Virology·Carla Osiowy
Dec 24, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Isabelle CheminChristian Trépo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
J H IrelandW F Carman
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Fadel AlhababiC Y William Tong
Journal of Medical Virology
Bernard WeberHolger Rabenau
© 2022 Meta ULC. All rights reserved